You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Open Orphan announces £2.5m influenza challenge study contract

Open Orphan has announced the signing of a £2.5m contract by its subsidiary hVIVO to conduct an influenza human challenge study with a US biotechnology company.